1. Home
  2. AXNX vs NPO Comparison

AXNX vs NPO Comparison

Compare AXNX & NPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXNX
  • NPO
  • Stock Information
  • Founded
  • AXNX 2012
  • NPO 2002
  • Country
  • AXNX United States
  • NPO United States
  • Employees
  • AXNX 797
  • NPO N/A
  • Industry
  • AXNX Medical/Dental Instruments
  • NPO Metal Fabrications
  • Sector
  • AXNX Health Care
  • NPO Industrials
  • Exchange
  • AXNX Nasdaq
  • NPO Nasdaq
  • Market Cap
  • AXNX 3.6B
  • NPO 3.4B
  • IPO Year
  • AXNX N/A
  • NPO N/A
  • Fundamental
  • Price
  • AXNX $70.45
  • NPO $162.48
  • Analyst Decision
  • AXNX Hold
  • NPO
  • Analyst Count
  • AXNX 8
  • NPO 0
  • Target Price
  • AXNX $71.00
  • NPO N/A
  • AVG Volume (30 Days)
  • AXNX 391.7K
  • NPO 97.3K
  • Earning Date
  • AXNX 11-07-2024
  • NPO 11-05-2024
  • Dividend Yield
  • AXNX N/A
  • NPO 0.73%
  • EPS Growth
  • AXNX N/A
  • NPO N/A
  • EPS
  • AXNX N/A
  • NPO 2.56
  • Revenue
  • AXNX $431,902,000.00
  • NPO $1,039,400,000.00
  • Revenue This Year
  • AXNX $25.35
  • NPO N/A
  • Revenue Next Year
  • AXNX $19.92
  • NPO $3.43
  • P/E Ratio
  • AXNX N/A
  • NPO $63.97
  • Revenue Growth
  • AXNX 26.08
  • NPO N/A
  • 52 Week Low
  • AXNX $55.09
  • NPO $123.56
  • 52 Week High
  • AXNX $70.75
  • NPO $176.13
  • Technical
  • Relative Strength Index (RSI)
  • AXNX 65.61
  • NPO 59.17
  • Support Level
  • AXNX $70.36
  • NPO $162.65
  • Resistance Level
  • AXNX $70.75
  • NPO $167.41
  • Average True Range (ATR)
  • AXNX 0.20
  • NPO 4.73
  • MACD
  • AXNX -0.02
  • NPO 1.77
  • Stochastic Oscillator
  • AXNX 62.50
  • NPO 74.80

About AXNX Axonics Inc.

Axonics Inc is a United States-based medical technology company. It focuses on developing and commercializing novel products for adults with bladder and bowel dysfunction, that include implantable SNM systems to treat urinary urge incontinence and urinary urgency frequency (UUF); a urethral bulking agent (Bulkamid) to treat female stress urinary incontinence. SNM therapy is predominantly used to treat patients with overactive bladder, fecal incontinence, and urinary retention. Geographically, the company generates majority of its revenue from United States and rest from International markets.

About NPO Enpro Inc.

Enpro Inc formerly EnPro Industries Inc is a United States-based company that designs, develops, manufactures, and markets proprietary engineered industrial products. The company operates through three segments: Sealing Technologies, which manufactures and markets sealing products, wheel-end components & systems, and Advanced Surface Technologies manufactures wafer processing sub-systems, thin-film coatings, optical filters, and other services like cleaning, coating, testing, and refurbishment. Its geographical segments are the United States, Europe, and other foreign countries.

Share on Social Networks: